P
Polaris Peptides
Request Full Data Access to the Medutest database of peptide tests.
Products examined
| Product | Rating | Samples | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| PT-141 | A | 6 | 7.4 | 6.7 | 9.0 | 6 Aug 2025 |
| GHK-Cu | A | 3 | 8.0 | 6.5 | 9.0 | 6 Aug 2025 |
| Tirzepatide | A | 15 | 8.8 | 6.5 | 10.0 | 17 Dec 2024 |
| Mazdutide | B | 3 | 6.1 | 5.7 | 6.5 | 30 Apr 2025 |
| Survodutide | B | 5 | 7.3 | 5.9 | 8.8 | 25 Apr 2025 |
| CJC-1295 | C | 4 | 6.5 | 4.1 | 7.4 | 13 Feb 2025 |
| BPC-157 | C | 11 | 6.2 | 4.5 | 7.9 | 17 Dec 2024 |
| Semaglutide | C | 16 | 6.9 | 4.7 | 8.7 | 17 Dec 2024 |
| Retatrutide | D | 26 | 7.3 | 3.9 | 9.0 | 17 Dec 2024 |
| (2-Chloroethyl)benzene CAS 622-24-2 | A | 6 | 7.4 | 5.7 | 9.1 | 17 May 2026 |
| ACE-031 | A | 9 | 7.9 | 4.5 | 10.0 | 21 May 2026 |
| AHK-CU | A | 2 | 6.4 | 5.1 | 7.7 | 17 May 2026 |
| Alprostadil | A | 5 | 6.2 | 5.4 | 6.8 | 24 May 2026 |
| Anadrol (Oxymetholone) | A | 9 | 7.3 | 4.6 | 9.3 | 24 May 2026 |
| BAM15 | A | 3 | 6.6 | 5.2 | 7.6 | 19 Jan 2026 |
| BMK methyl glycidate CAS 80532-66-7 | A | 6 | 6.1 | 2.9 | 8.9 | 21 May 2026 |
| BPC157 10mg + TB500 10mg Blend | A | 2 | 7.1 | 4.9 | 9.3 | 24 May 2026 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | A | 8 | 7.7 | 5.4 | 10.0 | 24 May 2026 |
| Dianabol | A | 5 | 7.4 | 5.6 | 8.6 | 24 May 2026 |
| DNP | A | 7 | 7.4 | 5.4 | 9.1 | 17 May 2026 |
| DSIP | A | 4 | 6.8 | 3.1 | 9.6 | 19 Jan 2026 |
| EPO | A | 3 | 6.3 | 3.6 | 8.9 | 20 May 2026 |
| GHRP-2 Acetate | A | 3 | 7.5 | 7.3 | 7.7 | 25 May 2026 |
| Halotestin (Fluoxymesterone) | X | 1 | 9.6 | 9.6 | 9.6 | 20 Jun 2025 |
| HCG | A | 3 | 7.4 | 7.3 | 7.7 | 24 May 2026 |
| HGH Fragment 176-191 | A | 2 | 7.4 | 7.0 | 7.8 | 19 Jan 2026 |
| Humanin | A | 2 | 6.7 | 6.4 | 7.0 | 20 May 2026 |
| IGF-1 LR3 | A | 8 | 7.5 | 6.3 | 10.0 | 26 Jan 2026 |
| KPV | A | 6 | 7.5 | 6.1 | 9.4 | 26 Jan 2026 |
| Lipo-B 216mg | X | 1 | 6.2 | 6.2 | 6.2 | 24 Apr 2025 |
| Minoxidil Oral | A | 4 | 7.6 | 6.2 | 9.0 | 20 May 2026 |
| MK-677 (Ibutamoren) | A | 4 | 9.2 | 8.4 | 10.0 | 19 Jan 2026 |
| MOTS-C | A | 5 | 7.1 | 5.1 | 9.4 | 24 May 2026 |
| MT-1 | X | 1 | 7.5 | 7.5 | 7.5 | 9 Jun 2025 |
| Oxytocin Acetate | A | 8 | 7.7 | 3.8 | 10.0 | 21 May 2026 |
| PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | A | 3 | 7.3 | 4.8 | 10.0 | 21 May 2026 |
| Prostamax | X | 1 | 10.0 | 10.0 | 10.0 | 2 Jul 2025 |
| Romosozumab | A | 4 | 6.3 | 5.4 | 7.4 | 21 May 2026 |
| Salbutamol | A | 4 | 7.6 | 5.3 | 10.0 | 23 May 2026 |
| Selank 10mg + Semax 10mg Blend | A | 8 | 6.2 | 4.6 | 7.1 | 21 May 2026 |
| SNAP-8 | X | 1 | 6.8 | 6.8 | 6.8 | 2 Jul 2025 |
| Stanozolol (Winstrol) Raw | A | 4 | 7.3 | 6.5 | 8.8 | 17 May 2026 |
| Supertest 450 | A | 6 | 7.5 | 4.9 | 9.7 | 17 May 2026 |
| T3 (Liothyronine) | A | 3 | 6.5 | 5.9 | 7.5 | 23 May 2026 |
| Telmisartan | A | 6 | 8.3 | 7.6 | 10.0 | 25 May 2026 |
| Test Enanthate | A | 9 | 7.1 | 5.6 | 8.3 | 21 May 2026 |
| Tren Hex Raw | A | 2 | 5.8 | 4.3 | 7.3 | 25 May 2026 |
| TriTren 225 | A | 2 | 5.4 | 5.3 | 5.6 | 21 May 2026 |
| Vitamin B12 10mg/ml | A | 7 | 8.1 | 4.2 | 10.0 | 24 May 2026 |
| Winstrol (Stanozolol) | A | 4 | 7.4 | 6.3 | 9.1 | 21 May 2026 |
The certificates
| Date | Product | Score | Declared | Measured | Deviation | Purity | Laboratory |
|---|---|---|---|---|---|---|---|
| 25 May 2026 | MT-1 | 9.3 | 5mg | 5.8mg | +15.6% | 98.08% | Lab G |
| 25 May 2026 | Supertest 450 | 7.6 | 200mg/ml | 182.2mg/ml | -8.9% | 96.55% | Lab A |
| 25 May 2026 | Test Enanthate | 5.6 | 300mg/ml | 315.3mg/ml | +5.1% | 95.73% | Lab C |
| 24 May 2026 | ACE-031 | 8.3 | 30mg | 29.9mg | -0.2% | 96.71% | Lab F |
| 24 May 2026 | ACE-031 | 6.4 | 5mg | 6.2mg | +24.9% | 95.91% | Lab B |
| 24 May 2026 | AHK-CU | 4.7 | 20mg | 18.8mg | -6.1% | 99.18% | Lab A |
| 24 May 2026 | Dianabol | 6.2 | 50mg | 48.0mg | -4.0% | 98.31% | Lab B |
| 24 May 2026 | MOTS-C | 6.4 | 2mg | 2.5mg | +24.2% | 95.62% | Lab E |
| 24 May 2026 | Test Enanthate | 8.4 | 200mg/ml | 245.6mg/ml | +22.8% | 99.27% | Lab D |
| 24 May 2026 | Test Enanthate | 6.3 | 100mg/ml | 87.6mg/ml | -12.4% | 96.12% | Lab D |
| 24 May 2026 | TriTren 225 | 4.0 | 100mg/ml | 88.3mg/ml | -11.7% | 98.21% | Lab D |
| 24 May 2026 | BPC157 10mg + TB500 10mg Blend | 7.0 | 5mg | 5.2mg | +4.0% | 98.25% | Lab G |
| 24 May 2026 | DNP | 7.5 | 50mg | 43.9mg | -12.1% | 99.01% | Lab F |
| 24 May 2026 | EPO | 7.0 | 10mg | 9.1mg | -9.4% | 95.90% | Lab F |
| 24 May 2026 | Humanin | 5.6 | 50mg | 62.1mg | +24.2% | 98.90% | Lab D |
| 24 May 2026 | IGF-1 LR3 | 8.8 | 10mg | 10.2mg | +1.8% | 98.56% | Lab A |
| 24 May 2026 | MK-677 (Ibutamoren) | 8.2 | 50mg | 52.2mg | +4.4% | 96.97% | Lab C |
| 24 May 2026 | Selank 10mg + Semax 10mg Blend | 6.9 | 15mg | 17.5mg | +16.4% | 95.75% | Lab F |
| 24 May 2026 | Stanozolol (Winstrol) Raw | 7.0 | 100g | 106.8g | +6.8% | 96.95% | Lab D |
| 24 May 2026 | T3 (Liothyronine) | 7.9 | 20mg | 23.0mg | +14.9% | 99.92% | Lab B |
| 24 May 2026 | BMK methyl glycidate CAS 80532-66-7 | 7.6 | 5g | 5.0g | +0.4% | 98.28% | Lab A |
| 24 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 6.8 | 50mg | 44.2mg | -11.7% | 99.47% | Lab G |
| 24 May 2026 | MOTS-C | 4.0 | 15mg | 14.1mg | -6.2% | 99.46% | Lab C |
| 24 May 2026 | Oxytocin Acetate | 8.1 | 2mg | 1.9mg | -3.5% | 95.66% | Lab B |
| 24 May 2026 | Salbutamol | 6.7 | 20mg | 19.1mg | -4.7% | 97.21% | Lab A |
| 24 May 2026 | Stanozolol (Winstrol) Raw | 8.2 | 1g | 1.0g | -1.3% | 98.20% | Lab F |
| 24 May 2026 | Test Enanthate | 4.0 | 200mg/ml | 191.5mg/ml | -4.2% | 95.10% | Lab G |
| 24 May 2026 | (2-Chloroethyl)benzene CAS 622-24-2 | 8.7 | 1g | 0.9g | -5.8% | 99.84% | Lab B |
| 24 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 8.9 | 10mg | 9.8mg | -2.1% | 96.51% | Lab C |
| 24 May 2026 | EPO | 4.0 | 15mg | 17.8mg | +18.5% | 98.43% | Lab B |
| 24 May 2026 | T3 (Liothyronine) | 6.7 | 50mg | 58.2mg | +16.4% | 98.23% | Lab D |
| 24 May 2026 | (2-Chloroethyl)benzene CAS 622-24-2 | 7.0 | 10g | 9.3g | -6.9% | 95.25% | Lab B |
| 24 May 2026 | ACE-031 | 9.0 | 15mg | 17.5mg | +16.6% | 99.00% | Lab G |
| 24 May 2026 | Oxytocin Acetate | 8.4 | 10mg | 10.3mg | +3.1% | 97.31% | Lab G |
| 24 May 2026 | Oxytocin Acetate | 5.8 | 10mg | 10.9mg | +8.6% | 95.47% | Lab C |
| 24 May 2026 | PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | 7.5 | 5g | 4.8g | -4.6% | 99.14% | Lab E |
| 24 May 2026 | Selank 10mg + Semax 10mg Blend | 6.5 | 15mg | 13.4mg | -10.6% | 97.72% | Lab D |
| 24 May 2026 | Vitamin B12 10mg/ml | 7.8 | 100mg/ml | 93.3mg/ml | -6.7% | 96.87% | Lab A |
| 23 May 2026 | AHK-CU | 7.3 | 10mg | 10.8mg | +8.2% | 95.46% | Lab F |
| 23 May 2026 | MK-677 (Ibutamoren) | 10.0 | 25mg | 28.4mg | +13.5% | 97.67% | Lab B |
| 23 May 2026 | MK-677 (Ibutamoren) | 10.0 | 10mg | 10.5mg | +5.3% | 96.28% | Lab B |
| 23 May 2026 | PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | 7.6 | 10g | 11.9g | +19.1% | 98.63% | Lab F |
| 23 May 2026 | Winstrol (Stanozolol) | 7.4 | 10mg | 10.2mg | +2.2% | 95.74% | Lab G |
| 23 May 2026 | IGF-1 LR3 | 8.7 | 30mg | 30.7mg | +2.3% | 98.98% | Lab B |
| 23 May 2026 | Selank 10mg + Semax 10mg Blend | 6.4 | 20mg | 17.7mg | -11.4% | 96.67% | Lab A |
| 23 May 2026 | Selank 10mg + Semax 10mg Blend | 4.0 | 30mg | 36.9mg | +22.9% | 96.32% | Lab C |
| 23 May 2026 | Telmisartan | 8.4 | 25mg | 22.7mg | -9.3% | 97.44% | Lab B |
| 23 May 2026 | Vitamin B12 10mg/ml | 7.5 | 300mg/ml | 316.8mg/ml | +5.6% | 96.78% | Lab F |
| 21 May 2026 | Alprostadil | 6.2 | 2mg | 2.5mg | +24.9% | 98.74% | Lab E |
| 21 May 2026 | Anadrol (Oxymetholone) | 5.1 | 10mg | 9.2mg | -7.7% | 99.34% | Lab A |
| 21 May 2026 | Anadrol (Oxymetholone) | 8.6 | 50mg | 59.7mg | +19.5% | 99.11% | Lab C |
| 21 May 2026 | BMK methyl glycidate CAS 80532-66-7 | 7.3 | 100g | 87.1g | -12.9% | 95.97% | Lab E |
| 21 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 7.4 | 15mg | 18.3mg | +21.7% | 95.08% | Lab F |
| 21 May 2026 | IGF-1 LR3 | 5.6 | 10mg | 11.4mg | +14.4% | 95.46% | Lab B |
| 21 May 2026 | Oxytocin Acetate | 8.1 | 50mg | 43.8mg | -12.3% | 96.49% | Lab E |
| 21 May 2026 | Stanozolol (Winstrol) Raw | 9.0 | 500g | 508.5g | +1.7% | 97.64% | Lab A |
| 21 May 2026 | Test Enanthate | 5.3 | 300mg/ml | 338.5mg/ml | +12.8% | 99.78% | Lab C |
| 21 May 2026 | Tren Hex Raw | 6.7 | 10g | 9.3g | -7.3% | 98.05% | Lab E |
| 21 May 2026 | BAM15 | 8.3 | 20mg | 20.5mg | +2.7% | 95.73% | Lab E |
| 21 May 2026 | Lipo-B 216mg | 7.2 | 250mg/ml | 227.9mg/ml | -8.8% | 99.40% | Lab A |
| 21 May 2026 | Minoxidil Oral | 8.7 | 25mg | 28.6mg | +14.3% | 97.14% | Lab C |
| 21 May 2026 | Romosozumab | 6.3 | 30mg | 35.1mg | +17.0% | 99.84% | Lab B |
| 21 May 2026 | Supertest 450 | 4.8 | 250mg/ml | 298.2mg/ml | +19.3% | 96.49% | Lab C |
| 20 May 2026 | ACE-031 | 7.9 | 10mg | 11.3mg | +12.8% | 97.61% | Lab C |
| 20 May 2026 | BMK methyl glycidate CAS 80532-66-7 | 5.0 | 1g | 1.2g | +15.5% | 95.14% | Lab B |
| 20 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 9.1 | 5mg | 4.3mg | -14.4% | 96.35% | Lab G |
| 20 May 2026 | Minoxidil Oral | 7.3 | 25mg | 27.2mg | +8.7% | 95.66% | Lab D |
| 20 May 2026 | PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | 7.1 | 5g | 4.5g | -9.9% | 97.99% | Lab F |
| 19 May 2026 | Alprostadil | 7.2 | 50mg | 60.1mg | +20.3% | 96.83% | Lab G |
| 19 May 2026 | Alprostadil | 7.7 | 10mg | 9.1mg | -9.5% | 96.51% | Lab E |
| 19 May 2026 | Anadrol (Oxymetholone) | 6.6 | 50mg | 55.1mg | +10.2% | 96.93% | Lab B |
| 19 May 2026 | DSIP | 7.4 | 5mg | 5.6mg | +12.1% | 98.48% | Lab A |
| 19 May 2026 | Humanin | 6.9 | 50mg | 55.4mg | +10.9% | 97.79% | Lab A |
| 19 May 2026 | Minoxidil Oral | 6.3 | 10mg | 12.0mg | +20.1% | 98.12% | Lab C |
| 19 May 2026 | Minoxidil Oral | 8.8 | 10mg | 9.1mg | -8.5% | 99.48% | Lab G |
| 19 May 2026 | Vitamin B12 10mg/ml | 7.8 | 300mg/ml | 331.5mg/ml | +10.5% | 99.27% | Lab C |
| 17 May 2026 | IGF-1 LR3 | 5.6 | 50mg | 52.3mg | +4.6% | 99.58% | Lab A |
| 17 May 2026 | KPV | 9.9 | 50mg | 57.3mg | +14.6% | 95.87% | Lab D |
| 17 May 2026 | Supertest 450 | 6.5 | 250mg/ml | 253.8mg/ml | +1.5% | 97.04% | Lab B |
| 29 Jan 2026 | Anadrol (Oxymetholone) | 6.9 | 25mg | 29.9mg | +19.7% | 95.35% | Lab C |
| 29 Jan 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 6.0 | 2mg | 2.3mg | +14.8% | 95.75% | Lab E |
| 29 Jan 2026 | Dianabol | 8.9 | 10mg | 8.6mg | -14.3% | 97.65% | Lab D |
| 29 Jan 2026 | HCG | 6.5 | 5mg | 4.9mg | -2.9% | 95.79% | Lab G |
| 29 Jan 2026 | KPV | 7.6 | 50mg | 61.3mg | +22.6% | 99.90% | Lab E |
| 29 Jan 2026 | Prostamax | 9.6 | 30mg | 34.1mg | +13.7% | 96.93% | Lab A |
| 29 Jan 2026 | Romosozumab | 4.0 | 5mg | 5.4mg | +8.8% | 99.81% | Lab B |
| 29 Jan 2026 | Selank 10mg + Semax 10mg Blend | 6.4 | 20mg | 17.6mg | -12.2% | 99.40% | Lab B |
| 29 Jan 2026 | SNAP-8 | 6.3 | 2mg | 2.3mg | +14.7% | 98.38% | Lab F |
| 29 Jan 2026 | Telmisartan | 6.5 | 10mg | 10.3mg | +2.8% | 97.07% | Lab B |
| 29 Jan 2026 | Vitamin B12 10mg/ml | 8.7 | 200mg/ml | 229.8mg/ml | +14.9% | 96.98% | Lab D |
| 26 Jan 2026 | Alprostadil | 8.0 | 50mg | 42.8mg | -14.4% | 96.31% | Lab B |
| 26 Jan 2026 | BMK methyl glycidate CAS 80532-66-7 | 4.1 | 1g | 1.2g | +20.4% | 95.84% | Lab E |
| 26 Jan 2026 | HGH Fragment 176-191 | 9.4 | 30mg | 28.7mg | -4.5% | 98.82% | Lab A |
| 26 Jan 2026 | Romosozumab | 8.2 | 50mg | 55.3mg | +10.5% | 96.04% | Lab A |
| 26 Jan 2026 | Supertest 450 | 7.4 | 300mg/ml | 366.0mg/ml | +22.0% | 98.01% | Lab G |
| 19 Jan 2026 | Tirzepatide | 8.7 | 30mg | (no batch claim) | 29mg | -3.3% | POL-T30-17 |
| 19 Jan 2026 | ACE-031 | 5.0 | 20mg | 17.3mg | -13.6% | 95.74% | Lab C |
| 19 Jan 2026 | HGH Fragment 176-191 | 6.8 | 2mg | 2.4mg | +22.2% | 99.91% | Lab D |
| 19 Jan 2026 | Oxytocin Acetate | 9.1 | 2mg | 2.3mg | +13.4% | 97.13% | Lab E |
| 19 Jan 2026 | Winstrol (Stanozolol) | 8.9 | 10mg | 10.5mg | +5.4% | 97.69% | Lab D |
| 9 Jan 2026 | ACE-031 | 5.9 | 10mg | 9.5mg | -4.9% | 99.42% | Lab G |
| 9 Jan 2026 | HCG | 5.8 | 5mg | 4.4mg | -11.8% | 98.06% | Lab C |
| 9 Jan 2026 | IGF-1 LR3 | 6.6 | 15mg | 17.1mg | +14.3% | 96.53% | Lab E |
| 9 Jan 2026 | Oxytocin Acetate | 7.6 | 50mg | 43.1mg | -13.7% | 97.70% | Lab D |
| 9 Jan 2026 | Salbutamol | 6.3 | 20mg | 20.8mg | +4.0% | 98.86% | Lab F |
| 9 Jan 2026 | Vitamin B12 10mg/ml | 7.5 | 200mg/ml | 222.3mg/ml | +11.2% | 99.24% | Lab C |
| 7 Jan 2026 | Retatrutide | 7.5 | 10mg | (no batch claim) | 10.4mg | +4.0% | (no batch ID) |
| 7 Jan 2026 | ACE-031 | 8.7 | 5mg | 4.3mg | -14.3% | 97.75% | Lab D |
| 7 Jan 2026 | Alprostadil | 6.4 | 10mg | 11.0mg | +10.1% | 96.42% | Lab D |
| 7 Jan 2026 | Anadrol (Oxymetholone) | 5.9 | 20mg | 23.1mg | +15.4% | 98.26% | Lab C |
| 7 Jan 2026 | BAM15 | 8.6 | 100mg | 99.1mg | -0.9% | 97.26% | Lab A |
| 7 Jan 2026 | DSIP | 7.5 | 2mg | 2.3mg | +15.7% | 98.81% | Lab E |
| 7 Jan 2026 | Selank 10mg + Semax 10mg Blend | 5.0 | 30mg | 28.2mg | -6.1% | 97.20% | Lab G |
| 7 Jan 2026 | Stanozolol (Winstrol) Raw | 6.4 | 100g | 100.9g | +0.9% | 99.31% | Lab D |
| 7 Jan 2026 | Telmisartan | 8.5 | 20mg | 20.9mg | +4.6% | 96.29% | Lab F |
| 7 Jan 2026 | Vitamin B12 10mg/ml | 8.6 | 300mg/ml | 341.4mg/ml | +13.8% | 99.38% | Lab F |
| 6 Jan 2026 | (2-Chloroethyl)benzene CAS 622-24-2 | 6.5 | 100g | 102.2g | +2.2% | 96.62% | Lab B |
| 6 Jan 2026 | Anadrol (Oxymetholone) | 6.7 | 25mg | 30.1mg | +20.2% | 96.08% | Lab D |
| 6 Jan 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 7.5 | 5mg | 5.2mg | +3.7% | 97.27% | Lab A |
| 6 Jan 2026 | MOTS-C | 8.7 | 10mg | 12.1mg | +21.4% | 97.13% | Lab D |
| 6 Jan 2026 | Oxytocin Acetate | 7.3 | 30mg | 35.4mg | +18.0% | 95.19% | Lab E |
| 6 Jan 2026 | Tren Hex Raw | 6.8 | 500g | 604.5g | +20.9% | 97.48% | Lab B |
| 6 Jan 2026 | Winstrol (Stanozolol) | 7.3 | 25mg | 25.3mg | +1.3% | 99.60% | Lab B |
| 29 Dec 2025 | (2-Chloroethyl)benzene CAS 622-24-2 | 6.2 | 10g | 10.0g | +0.5% | 97.86% | Lab B |
| 29 Dec 2025 | (2-Chloroethyl)benzene CAS 622-24-2 | 7.2 | 5g | 4.4g | -12.4% | 97.59% | Lab D |
| 29 Dec 2025 | BMK methyl glycidate CAS 80532-66-7 | 5.2 | 1g | 1.0g | -4.4% | 98.00% | Lab A |
| 29 Dec 2025 | Dianabol | 6.0 | 100mg | 100.7mg | +0.7% | 97.95% | Lab C |
| 29 Dec 2025 | DNP | 8.4 | 100mg | 111.2mg | +11.2% | 95.31% | Lab F |
| 29 Dec 2025 | DNP | 6.1 | 50mg | 60.1mg | +20.3% | 95.21% | Lab B |
| 29 Dec 2025 | DSIP | 7.7 | 20mg | 19.0mg | -4.9% | 96.76% | Lab D |
| 29 Dec 2025 | Test Enanthate | 5.7 | 100mg/ml | 124.5mg/ml | +24.5% | 97.19% | Lab E |
| 29 Dec 2025 | Test Enanthate | 9.3 | 250mg/ml | 269.2mg/ml | +7.7% | 98.14% | Lab C |
| 12 Dec 2025 | BAM15 | 6.2 | 25mg | 23.1mg | -7.7% | 98.18% | Lab D |
| 12 Dec 2025 | Dianabol | 6.3 | 100mg | 104.8mg | +4.8% | 95.39% | Lab A |
| 12 Dec 2025 | DNP | 10.0 | 20mg | 18.0mg | -9.9% | 99.53% | Lab F |
| 12 Dec 2025 | Selank 10mg + Semax 10mg Blend | 9.1 | 15mg | 13.4mg | -10.9% | 96.05% | Lab E |
| 5 Dec 2025 | ACE-031 | 8.1 | 2mg | 2.1mg | +5.9% | 97.13% | Lab D |
| 5 Dec 2025 | Anadrol (Oxymetholone) | 8.6 | 20mg | 23.6mg | +17.9% | 97.12% | Lab C |
| 5 Dec 2025 | DNP | 6.8 | 50mg | 53.5mg | +7.1% | 98.96% | Lab G |
| 5 Dec 2025 | IGF-1 LR3 | 7.0 | 15mg | 17.2mg | +14.9% | 96.43% | Lab B |
| 5 Dec 2025 | MK-677 (Ibutamoren) | 9.6 | 100mg | 95.5mg | -4.5% | 98.17% | Lab F |
| 5 Dec 2025 | Salbutamol | 7.0 | 10mg | 9.0mg | -9.6% | 96.56% | Lab B |
| 5 Dec 2025 | Supertest 450 | 7.0 | 100mg/ml | 108.3mg/ml | +8.3% | 99.01% | Lab A |
| 25 Nov 2025 | GHK-Cu | 8.4 | 50mg | 68.4mgwebsite | 73.1mg | +6.9% | POL-GC50-4 |
| 23 Nov 2025 | (2-Chloroethyl)benzene CAS 622-24-2 | 8.2 | 1g | 1.0g | +4.1% | 96.48% | Lab C |
| 23 Nov 2025 | Supertest 450 | 7.8 | 100mg/ml | 104.2mg/ml | +4.2% | 95.45% | Lab B |
| 23 Nov 2025 | T3 (Liothyronine) | 6.1 | 50mg | 47.1mg | -5.7% | 98.53% | Lab C |
| 23 Nov 2025 | Test Enanthate | 4.5 | 100mg/ml | 115.8mg/ml | +15.8% | 99.69% | Lab F |
| 17 Nov 2025 | Anadrol (Oxymetholone) | 7.9 | 20mg | 23.2mg | +16.0% | 96.67% | Lab F |
| 17 Nov 2025 | GHRP-2 Acetate | 10.0 | 50mg | 54.2mg | +8.3% | 96.13% | Lab B |
| 17 Nov 2025 | GHRP-2 Acetate | 8.2 | 10mg | 11.2mg | +11.6% | 96.01% | Lab A |
| 17 Nov 2025 | IGF-1 LR3 | 6.9 | 20mg | 23.0mg | +15.2% | 98.53% | Lab A |
| 17 Nov 2025 | MOTS-C | 7.6 | 15mg | 14.6mg | -2.6% | 95.35% | Lab A |
| 14 Nov 2025 | ACE-031 | 7.5 | 30mg | 32.8mg | +9.3% | 96.17% | Lab A |
| 14 Nov 2025 | EPO | 4.8 | 10mg | 9.7mg | -2.8% | 95.84% | Lab B |
| 14 Nov 2025 | KPV | 5.3 | 2mg | 2.3mg | +13.3% | 99.66% | Lab E |
| 14 Nov 2025 | Telmisartan | 10.0 | 50mg | 61.0mg | +22.0% | 99.50% | Lab C |
| 7 Nov 2025 | GHK-Cu | 9.0 | 50mg | 68.4mgwebsite | 69.35mg | +1.4% | POL-GC50-4 |
| 5 Nov 2025 | DNP | 8.7 | 50mg | 47.2mg | -5.6% | 96.21% | Lab A |
| 5 Nov 2025 | GHRP-2 Acetate | 7.8 | 5mg | 4.7mg | -6.5% | 97.87% | Lab A |
| 5 Nov 2025 | Halotestin (Fluoxymesterone) | 9.6 | 25mg | 27.9mg | +11.6% | 98.34% | Lab C |
| 5 Nov 2025 | Salbutamol | 7.9 | 100mg | 102.8mg | +2.8% | 97.18% | Lab D |
| 5 Nov 2025 | Telmisartan | 6.8 | 20mg | 24.2mg | +20.8% | 99.28% | Lab B |
| 5 Nov 2025 | Test Enanthate | 6.5 | 300mg/ml | 282.1mg/ml | -6.0% | 97.67% | Lab E |
| 4 Nov 2025 | BMK methyl glycidate CAS 80532-66-7 | 7.2 | 100g | 98.0g | -2.0% | 97.33% | Lab C |
| 4 Nov 2025 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 5.0 | 2mg | 2.2mg | +9.7% | 97.31% | Lab B |
| 4 Nov 2025 | DSIP | 5.1 | 20mg | 18.5mg | -7.7% | 96.97% | Lab E |
| 4 Nov 2025 | KPV | 6.8 | 5mg | 5.4mg | +7.9% | 99.05% | Lab E |
| 4 Nov 2025 | KPV | 7.6 | 2mg | 2.0mg | -0.0% | 99.06% | Lab D |
| 4 Nov 2025 | Oxytocin Acetate | 7.5 | 2mg | 1.7mg | -15.0% | 95.17% | Lab D |
| 4 Nov 2025 | Telmisartan | 10.0 | 25mg | 22.9mg | -8.3% | 96.69% | Lab E |
| 4 Nov 2025 | Winstrol (Stanozolol) | 7.1 | 20mg | 18.1mg | -9.5% | 95.07% | Lab C |
| 17 Oct 2025 | BPC157 10mg + TB500 10mg Blend | 7.6 | 15mg | 13.9mg | -7.1% | 98.29% | Lab D |
| 17 Oct 2025 | Dianabol | 8.7 | 20mg | 21.7mg | +8.7% | 96.53% | Lab G |
| 17 Oct 2025 | KPV | 8.5 | 5mg | 4.9mg | -2.6% | 97.58% | Lab E |
| 17 Oct 2025 | Romosozumab | 6.9 | 20mg | 24.0mg | +20.1% | 95.31% | Lab B |
| 17 Oct 2025 | TriTren 225 | 4.6 | 300mg/ml | 322.0mg/ml | +7.3% | 96.62% | Lab G |
| 9 Oct 2025 | Retatrutide | 7.7 | 5mg | (no batch claim) | 4.53mg | -9.4% | 520250728F |
| 9 Oct 2025 | DNP | 6.7 | 20mg | 21.5mg | +7.6% | 96.34% | Lab C |
| 9 Oct 2025 | Selank 10mg + Semax 10mg Blend | 7.0 | 50mg | 54.9mg | +9.8% | 95.14% | Lab F |
| 9 Oct 2025 | Vitamin B12 10mg/ml | 9.1 | 100mg/ml | 112.9mg/ml | +12.9% | 99.07% | Lab F |
| 3 Oct 2025 | Anadrol (Oxymetholone) | 6.4 | 50mg | 61.6mg | +23.3% | 98.57% | Lab C |
| 3 Oct 2025 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 9.5 | 30mg | 36.9mg | +22.9% | 96.49% | Lab D |
| 3 Oct 2025 | HCG | 6.1 | 2mg | 1.9mg | -6.6% | 96.14% | Lab B |
| 3 Oct 2025 | IGF-1 LR3 | 7.6 | 5mg | 4.7mg | -6.5% | 97.25% | Lab C |
| 3 Oct 2025 | MOTS-C | 7.1 | 30mg | 30.0mg | -0.1% | 99.41% | Lab C |
| 1 Oct 2025 | BPC-157 | 4.5 | 10mg | 11.4mgwebsite | 12.55mg | +9.8% | POL-BPC10-4 |
| 1 Oct 2025 | BPC-157 | 6.0 | 5mg | 6.5mgwebsite | 6.14mg | -5.7% | POL-BPC5-2 |